Beilstein J. Org. Chem. 2012, 8, 472–485.
CH2COO), 1.97 (m, 8H, 4 × CH2); 13C NMR (125 MHz, Thia-Ox/5: 4-[3-(4-{6-[4-(5-Heptyl-1,3,4-thiadiazol-2-
CDCl3) δ 175.01, 171.44, 171.21, 168.30, 159.50, 159.48, yl)phenoxy]hexanoyloxy}phenyl)-1,2,4-oxadiazol-5-yl]phenyl
154.13, 152.94, 145.19, 145.16, 132.55, 131.57, 131.54, 129.63, 4-hexylbenzoate; colorless solid; yield 69%; 1H NMR (400
128.84, 128.36, 127.08, 124.48, 122.43, 122.08, 121.76, 119.03, MHz, CDCl3) δ 8.24 (d, J = 8.8 Hz, 2H, Ar), 8.15 (d, J = 8.8
115.08, 115.06, 110.15, 110.12, 67.46, 67.43, 33.96, 28.52, Hz, 2H, Ar), 8.07 (d, J = 8.4 Hz, 2H, Ar), 7.80 (d, J = 8.8 Hz,
21.60, 21.57; Anal. calcd for C50H40N4O7: C, 74.24; H, 4.98; 2H, Ar), 7.38 (d, J = 8.8 Hz, 2H, Ar), 7.28 (d, J = 8.8 Hz, 2H,
N, 6.93; found: C, 73.94; H, 4.74; N, 6.62.
Ar), 7.19 (d, J = 8.4 Hz, 2H, Ar), 6.91 (d, J = 8.8 Hz, 2H, Ar),
4.01 (t, J = 6.4 Hz, 2H, 1 × OCH2), 3.05 (t, J = 7.6 Hz, 2H, 1 ×
CH2), 2.66 (t, J = 7.2 Hz, 2H, 1 × CH2), 2.60 (t, J = 7.2 Hz, 2H,
CH2COO), 1.80–0.82 (m, 30H, 12 × CH2, 2 × CH3); Anal.
Preparation of the dimesogens CB-Ox/n and
Thia-Ox/n
A mixture of 4-[3-(4-hydroxyphenyl)-1,2,4-oxadiazol-5-yl]phe- calcd for C48H54N4O6S: C, 70.74; H, 6.87; N, 5.87; found: C,
nyl 4-hexylbenzoate (3) [67] (0.34 mmol, 1 equiv), ω-(4’- 70.57; H, 6.54; N, 6.67.
cyanobiphenyl-4’-yloxy)alkanoic acid (2a,b) [66] (0.34 mmol,
1 equiv) or ω-[4-(5-heptyl-1,2,4-thiadiazol-2yl)phenoxy]alka- Thia-Ox/10: 4-[3-(4-{11-[4-(5-Heptyl-1,3,4-thiadiazol-2-
noic acids (4a,b) [66] (0.34 mmol, 1 equiv) and a catalytic yl)phenoxy]undecanoyloxy}-phenyl)-1,2,4-oxadiazol-5-yl]phe-
amount of DMAP were dissolved in dry CH2Cl2. To the above nyl 4-hexylbenzoate; colorless solid; yield 72%; 1H NMR (400
clear solution, N,N’-dicyclohexylcarbodiimide (DCC, 0.51 MHz, CDCl3) δ 8.23 (d, J = 8.8 Hz, 2H, Ar), 8.14 (d, J = 8.8
mmol, 1.1 equiv) was added and stirred for 12 h at rt, followed Hz, 2H, Ar), 8.07 (d, J = 8.4 Hz, 2H, Ar), 7.79 (d, J = 8.8 Hz,
by solvent evaporation and column chromatography with 2H, Ar), 7.37 (d, J = 8.8 Hz, 2H, Ar), 7.27 (d, J = 8.8 Hz, 2H,
EtOAc/n-hexane 2:8 to yield a solid, which was further puri- Ar), 7.18 (d, J = 8.4 Hz, 2H, Ar), 6.89 (d, J = 8.8 Hz, 2H, Ar),
fied by crystallization from EtOAc/EtOH 2:8.
3.96 (t, J = 6.4 Hz, 2H, 1 × OCH2), 3.05 (t, J = 7.6 Hz, 2H, 1 ×
CH2), 2.66 (t, J = 7.2 Hz, 2H, 1 × CH2), 2.54 (t, J = 7.2 Hz, 2H,
CB-Ox/3: 4-(3-{4-[4-(4’-Cyanobiphenyl-4-yl)oxybutanoyl- CH2COO), 1.77–0.79 (m, 40H, 17 × CH2, 2 × CH3); 13C NMR
oxy]phenyl}-1,2,4-oxadiazol-5-yl)phenyl 4-hexylbenzoate; (125 MHz, CDCl3) δ 175.09, 171.85, 169.47, 168.33, 168.11,
colorless solid; yield 70%; 1H NMR (400 MHz, CDCl3) δ 8.24 164.60, 161.27, 154.57, 153.03, 149.87, 130.34, 129.66, 129.27,
(d, J = 8.8 Hz, 2H, Ar), 8.16 (d, J = 8.8 Hz, 2H, Ar), 8.07 (d, J 128.83, 128.76, 126.35, 124.43, 122.86, 122.67, 122.11, 121.73,
= 8.4 Hz, 2H, Ar), 7.64 (dd, 1J = 8.8 Hz, 2J = 8.8 Hz, 4H, Ar), 114.91, 68.18, 36.09, 34.38, 31.62, 31.61, 31.03, 30.17, 30.05,
7.49 (d, J = 8.4 Hz, 2H, Ar), 7.38 (d, J = 8.8 Hz, 2H, Ar), 7.28 29.43, 29.31, 29.30, 29.18, 29.12, 29.04, 28.94, 28.87, 28.86,
(d, J = 8.4 Hz, 2H, Ar), 7.21 (d, J = 8.8 Hz, 2H, Ar), 6.96 (d, J 25.96, 24.84, 22.55, 22.54, 14.03, 14.02; Anal. calcd for
= 8.8 Hz, 2H, Ar), 4.11 (t, J = 6.0 Hz, 2H, 1 × OCH2), 2.81 (t, J C53H64N4O6S: C, 71.92; H, 7.29; N, 6.33; found: C, 71.65; H,
= 7.2 Hz, 2H, 1 × CH2), 2.67 (t, J = 7.6 Hz, 2H, CH2COO), 7.25; N, 6.29.
2.23 (m, 2H, CH2), 1.63–1.12 (m, 8H, 4× CH2), 0.84 (t, J = 6.8
Hz, 3H, 1 × CH3); 13C NMR (125 MHz, CDCl3) δ 175.13, Acknowledgements
171.24, 168.29, 164.61, 159.36, 154.60, 152.88, 149.89, 145.15, This work was supported by the EU within the FP7 funded
132.55, 131.74, 130.34, 129.67, 128.87, 128.77, 128.40, 127.11, Collaborative Project BIND (Grant No 216025) and the Cluster
126.33, 124.60, 122.69, 122.06, 121.71, 119.03, 115.10, 110.18, of Excellence “Nanostructured Materials”.
66.71, 36.09, 31.62, 31.04, 30.97, 28.88, 24.52, 22.54, 14.03;
References
1. Imrie, C. T.; Henderson, P. A.; Yeap, G.-Y. Liq. Cryst. 2009, 36,
Anal. calcd for C44H39N3O6: C, 74.88; H, 5.57; N, 5.95; found:
C, 74.58; H, 5.27; N, 5.69.
2. Goodby, J. W.; Saez, I. M.; Cowling, S. J.; Gasowska, J. S.;
CB-Ox/4: 4-(3-{4-[5-(4’-Cyanobiphenyl-4-yloxy)pentanoy-
MacDonald, R. A.; Sia, S.; Watson, P.; Toyne, K. J.; Hird, M.;
loxy]phenyl}-1,2,4-oxadiazol-5-yl)phenyl 4-hexylbenzoate;
Lewis, R. A.; Lee, S.-E.; Vaschenko, V. Liq. Cryst. 2009, 36, 567–605.
colorless solid; yield 74%; 1H NMR (400 MHz, CDCl3) δ 8.23
(d, J = 7.2 Hz, 2H, Ar), 8.14 (d, J = 6.8 Hz, 2H, Ar), 8.07 (d, J
= 6.4 Hz, 2H, Ar), 7.63 (dd, 1J = 6.8 Hz, 2J = 6.8 Hz, 4H, Ar),
7.48 (d, J = 6.8 Hz, 2H, Ar), 7.38 (d, J = 6.8 Hz, 2H, Ar), 7.28
(d, J = 6.4 Hz, 2H, Ar), 7.20 (d, J = 7.2 Hz, 2H, Ar), 6.96 (d, J
= 6.8 Hz, 2H, Ar), 4.04 (t, J = 4.4 Hz, 2H, 1 × OCH2), 2.66 (t, J
= 6.0 Hz, 4H, 2 × CH2), 1.93–1.24 (m, 12H, 6× CH2), 0.84 (t, J
= 5.6 Hz, 3H, 1 × CH3); Anal. calcd for C45H41N3O6: C, 75.09;
H, 5.74; N, 5.84; found: C, 74.95; H, 5.61; N, 5.65.
3. Imrie, C. T. Liquid Crystal Dimers. In Liquid Crystals II;
Mingos, D. M. P., Ed.; Structure and Bonding, Vol. 95; Springer: Berlin,
Germany, 1999; pp 149–192.
4. Imrie, C. T.; Henderson, P. A. Chem. Soc. Rev. 2007, 36, 2096–2124.
5. Abe, A.; Furuya, H.; Zhou, Z.; Hiejima, T.; Kobayashi, Y.
6. Ungar, G.; Percec, V.; Zuber, M. Macromolecules 1992, 25, 75–80.
483